Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-2.66%
Shrank
—
0.00%
Shrank
—
1 Year
Score—
Net Growth-2.66%
Net TrendShrank
Net Income Consistency—
Rev Growth0.00%
Rev TrendShrank
Revenue Consistency—
Pyxis Oncology Inc fundamental performance
Across Pyxis Oncology Inc's full reported history, from 2021 to 2025, revenue grew from $ 0.00 to $ 13M and net income went from -$ 75M to -$ 79M. Revenue increased in 20% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.18 | — |
1 Year2025-08-12 | $ 1.04 | 205.77% |
All Time2021-10-08 | $ 13.20 | -75.91% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2021-10-08 |
|---|---|---|---|
| Price | $ 3.18 | $ 1.04 | $ 13.20 |
| Return | — | 205.77% | -75.91% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 13M | -$ 81M | $ 42M |
| 2025 | $ 13M | -$ 79M | $ 66M |
| 2024 | $ 16M | -$ 77M | $ 126M |
| 2023 | $ 0.00 | -$ 73M | $ 119M |
| 2022 | $ 0.00 | -$ 117M | $ 179M |
| IPO2021 | $ 0.00 | -$ 75M | $ 274M |
Explore beyond PYXS
You're looking at Pyxis Oncology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
